Table 1.
Cytokine systems and cytokine/signalling cascades | Specific comments |
---|---|
Soluble and membrane-bound TNF | Distinct roles in autoimmunity versus risk of infection |
Immunomodulatory effects by TNF blockade on CD4+CD25+ Treg cells | |
TNFR1 and FDCs | Potential crucial role in autoimmunity |
STAT1/3 balance | IL-10 resistance can be modulated by TNF and IFN |
IL-17 | Counter regulation of Th17 versus Treg cells and emerging role of TH17 cells in providing B-cell help |
IL-33 | Potential role in resistance to intestinal nematode infection; proinflammatory effects in asthma and arthritis |
IL-35 | Probably immunosuppressive cytokine with potential to expand Treg cells and suppresses Th17 cells |
IL-6/IL-6 receptor/glycoprotein 130 | Additional role of this cytokine/signalling system in juvenile arthritis as well as other systemic autoimmune disorders. Role of IL-6/IL-6 receptor in glucose metabolism |
Cytokine/chemokine effects on osteoblast/osteoclast activity | TNFα, IL-1, IL-17A, IL-6, BAFF/BLyS, APRIL, C-C chemokine receptor 2 |
BAFF/BLyS, APRIL, TNF, IFNα | Role in systemic autoimmunity (that is, systemic lupus erythematosus) |
GM-CSF receptor blockade | First trial data in human |
Blockade of IL-17A | First trial data in rheumatoid arthritis patients |
IL-21 | Role in autoimmunity and potential target of therapy |
IL-22 | Potential to polarise Th17 cells into immunomodulatory IL-22-producing T cells |
IL-10 | Additional functions of IL-10-producing B cells for immunomodulation |
IFNα | Current and new aspects of using IFNα in the treatment of Behçet's disease |
APRIL, a proliferation-inducing ligand; BAFF, B-cell activating factor belonging to the TNF family; BLyS, B-lymphocyte stimulator; FDC, follicular dendritic cells; GM-CSF, granulocyte/macrophage colony-stimulating factor; STAT, signal transducer and activator of transcription; TNFR1, TNF receptor 1; Treg, T-regulatory.